我要投票 贝瑞和康在医疗器械行业中的票数:444
· 外 推 电 报 ·
2025-08-18 06:03:52 星期一

【贝瑞和康是哪个国家的品牌?】

贝瑞和康是什么牌子?「贝瑞和康」是 北京贝瑞和康生物技术有限公司 旗下著名品牌。该品牌发源于北京市,由创始人高扬在2010-05-18期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力贝瑞和康品牌出海!将品牌入驻外推网,定制贝瑞和康品牌推广信息,可以显著提高贝瑞和康产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

北京贝瑞和康生物技术有限公司成立于2010年5月,是专注应用高通量基因测序技术,为临床医学疾病筛查和诊断提供整体解决方案的研发型生物科技公司。

在生物医药晋升为“国家战略性新兴产业”的行业背景下,贝瑞基因凭借自主研发的核心技术,将人类基因组测序技术实践于临床检测。在先天性遗传疾病筛查和诊断领域,贝瑞基因开发出具有全套自主知识产权的贝比安“DNA产前检测”技术(简称贝比安),实现了胎儿染色体疾病的产前检测。随后,可用于婚前孕前、产前及遗传疾病先证者的科诺安染色体疾病检测(简称科诺安)、可用于辅助生殖技术中胚胎植入前染色体数目及结构异常的科孕安胚胎植入前遗传学筛查(简称科孕安)检测相继问世,进一步丰富完善了遗传病筛查与诊断的检测技术体系。在此基础上,贝瑞和康又先后研制开发出针对胎儿染色体微缺失微重复和胎儿单基因疾病基因分型的检测技术,以期实现安全、全覆盖的临床遗传疾病筛查与诊断模式。

在向遗传病筛查与诊断领域不断深入的同时,贝瑞基因在肿瘤分子诊断领域成功推出了基于高通量测序技术的昂科益(Onconi)肿瘤分子诊断产品,涉及靶向用药检测、疗效监测、用药监测、肿瘤易感性检测、肿瘤个体化医疗检测,实现肿瘤分子检测的整体覆盖。其中以具有自主知识产权的cSMART技术为核心的肿瘤基因检测为临床开启了模式。此外,贝瑞基因在产前检测、孕前检测、遗传病检测以及肿瘤检测领域累积的数据,已构建为具有中国人群特色的基因组大数据库。通过与贝勒医学院、阿里云等机构合作,贝瑞基因未来将借助云存储与云计算平台,实现基因组数据简化的终端应用和实时共享。

至此,贝瑞基因形成了从染色体数目和结构水平、染色体微缺失微重复水平、基因水平的技术维度层层深入;从婚前、孕前、产前、新生儿、癌症的产品维度渐次覆盖;从单个个体基因组数据解读到群体基因组数据分析,再到指导性个体基因组数据解读的数字化维度逐级递进的三维立体发展结构。



英文翻译:Beijing Beirui Hekang Biotechnology Co., Ltd. was founded in May 2010. It is a R & D biotechnology company that focuses on the application of high-throughput gene sequencing technology to provide overall solutions for clinical medical disease screening and diagnosis. Under the background of the promotion of biomedical industry to "national strategic emerging industry", berry gene, relying on the core technology of independent research and development, practices the human genome sequencing technology in clinical detection. In the field of screening and diagnosis of congenital genetic diseases, Berea gene has developed a complete set of bebian "DNA prenatal testing" technology (bebian for short) with independent intellectual property rights, which realizes the prenatal testing of fetal chromosomal diseases. Subsequently, konoan chromosomal disease detection (konoan for short) which can be used in premarital pregnancy, prenatal and genetic disease proband, and konoan genetic screening (konoan for short) which can be used in the number and structure of pre implantation chromosomes in the assisted reproductive technology, have come out successively, further enriching and improving the detection technology system of genetic disease screening and diagnosis 。 On this basis, berry and Kang have developed the detection technology for fetal chromosome microdeletion and microduplication and fetal single gene disease genotyping, in order to achieve a safe and full coverage of clinical genetic disease screening and diagnosis mode. In the field of genetic disease screening and diagnosis, berry gene has successfully launched onconi tumor molecular diagnosis products based on high-throughput sequencing technology in the field of tumor molecular diagnosis, involving targeted drug testing, efficacy monitoring, drug monitoring, tumor susceptibility testing, tumor individualized medical testing, to achieve the overall coverage of tumor molecular testing. Among them, the tumor gene detection, which is based on the smart technology with independent intellectual property rights, has opened a model for clinical practice. In addition, the data accumulated in the fields of prenatal test, pre pregnancy test, genetic disease test and tumor test of berry gene have been constructed into a large genome database with Chinese characteristics. Through cooperation with Baylor Medical College, Alibaba cloud and other institutions, Bayley gene will use cloud storage and cloud computing platform to realize terminal application and real-time sharing of genome data simplification in the future. So far, berry gene has formed a digital dimension from chromosome number and structure level, chromosome microdeletion and microduplication level, gene level; from premarital, pre pregnancy, prenatal, newborn, cancer product dimensions gradually covered; from single individual genome data interpretation to group genome data analysis to guiding individual genome data interpretation The three-dimensional development structure of degree progressive.

本文链接: https://www.waitui.com/brand/b653685ec.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

我国首个搭载气象雷达的海上升压站完成安装

8月16日,我国首个搭载气象雷达的海上升压站,在三峡江苏大丰800兆瓦海上风电项目现场完成安装,该设施将实现海洋气象精细化监测与海上风电场高效运行的协同应用,为海上清洁能源开发提供新模式。(央视新闻)

4分钟前

南微医学:中科招商拟减持不超过2%公司股份

36氪获悉,南微医学公告,公司股东中科招商因自身资金需求,拟通过上海证券交易所交易系统以集中竞价、大宗交易方式减持公司股份合计不超过3,756,948股,不超过公司总股本的2%。其中,通过集中竞价交易方式减持不超过1,878,474股,通过大宗交易方式减持不超过1,878,474股。减持期间为2025年9月9日至2025年12月7日。

4分钟前

骑手升级为“城市骑士”,饿了么淘宝闪购全面提升骑士保障激励体系

8月17日,饿了么董事长兼CEO范禹发布内部信,宣布平台全体骑手正式升级为“城市骑士”,全面升级骑士保障、激励、关怀和发展体系,并计划骑士制服换装。

4分钟前

李家超晤李彦宏,听取百度对自动驾驶产业发展意见

据报道,百度近年积极在香港推动自动驾驶业务“萝卜快跑”,适逢行政长官李家超正就新一份施政报告听取各界人士意见,李家超15日与运输及物流局局长陈美宝、特首政策组组长黄元山及行政长官办公室主任叶文娟等官员,与百度创办人李彦宏等一行人会面,听取百度对人工智能技术发展及自动驾驶技术在香港的应用场景、产业落地等事宜的意见。(新浪财经)

4分钟前

智元机器人发布OmniHand 2025灵巧手

36氪获悉,8月17日,智元机器人正式推出 OmniHand 2025 系列灵巧手,包含面向交互服务的“灵动款”与专注专业作业的“专业款”两大产品。其中,灵动款2025灵巧手指导价1.48万元,灵动触觉款首发线上价1.48万元(原价1.98万元)。

4分钟前

本页详细列出关于贝瑞和康的品牌信息,含品牌所属公司介绍,贝瑞和康所处行业的品牌地位及优势。
咨询